About
BE Therapeutics develops engineered stem cell-derived brain and spinal cord tissue to replace damaged central nervous system tissue and restore lost neurological functions through biomaterial-supported tissue constructs.
Explore BE Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.